Zelboraf 240 mg

Zelboraf 240 mg is a medicine authorised by Swissmedic under authorisation number 62139. The authorisation holder is Roche Pharma (Schweiz) AG. The medicinal product code is Synthetic medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 18 October 2011 and the authorisation is valid without a time limit. ATC code L01EC01 places the medicine in the group Antineoplastic agents.

Dispensing category A
Authorisation number 62139
ATC L01EC01
Synthetic medicines

Authorisation data
Authorisation number	62139
Name	Zelboraf 240 mg
Full name	Zelboraf 240 mg, Filmtabletten
Authorisation holder	Roche Pharma (Schweiz) AG
Medicinal product code	Synthetic medicines
Dispensing category	A · Prescription, not repeatable
ATC code	L01EC01
First authorisation	18 October 2011
Authorisation validity	unlimited

Strengths
No.	Name	Dispensing category	Authorisation date
1	Zelboraf 240 mg, Filmtabletten	A	18 October 2011

Scroll the table sideways

Pack sizes
Pack code	Quantity	Unit	ATC	IT code	Dispensing category
1	56	Tablette(n)	L01EC01	07.16.1.	A

Scroll the table sideways

Other medicines from this authorisation holder

Actemra 162 mg/0.9 mlAuthorisation number 63166 · ATC L04AC07A Actemra 162 mg/0.9 mlAuthorisation number 66931 · ATC L04AC07A Actemra 80 mg/4 mlAuthorisation number 58868 · ATC L04AC07A Alecensa 150 mgAuthorisation number 65970 · ATC L01ED03A Avastin 100 mg/4 mlAuthorisation number 56922 · ATC L01FG01A CellceptAuthorisation number 54701 · ATC L04AA06B Cellcept 250 mgAuthorisation number 53337 · ATC L04AA06B Cellcept 500 mgAuthorisation number 53338 · ATC L04AA06B

Frequently asked questions

Is Zelboraf 240 mg authorised in Switzerland?

Yes. Zelboraf 240 mg is authorised by Swissmedic under authorisation number 62139, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does Zelboraf 240 mg have?

Zelboraf 240 mg is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.

Who is the authorisation holder of Zelboraf 240 mg?

The authorisation holder is Roche Pharma (Schweiz) AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.